BIG
IOVA icon

Brooklyn Investment Group’s Iovance Biotherapeutics IOVA Stock Holding History

Brooklyn Investment Group’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.9K Buy
+17,635
New +$56.4K ﹤0.01% 1815
2025
Q4 		– Sell
-40,445
Closed -$68.4K – 1530
2025
Q3 		$68.4K Sell
40,445
-6,107
-13% -$14.4K 0.01% 653
2025
Q2 		$80.1K Buy
46,552
+43,678
+1,520% +$109K 0.01% 1066
2025
Q1 		$9.57K Buy
2,874
+2,629
+1,073% +$13.6K ﹤0.01% 1533
2024
Q4 		$1.81K Buy
+245
New +$2.27K ﹤0.01% 1491

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Brooklyn Investment Group's IOVA Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in Iovance Biotherapeutics (IOVA) in Q1 2026: 17,635 shares worth $61.9K. The stake represents ﹤0.01% of the portfolio and ranks #1815 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in IOVA as recently as Q3 2025.

Brooklyn Investment Group first reported a position in IOVA in Q4 2024 and has held it in 5 quarters since. The position peaked at $80.1K in Q2 2025. 286 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Brooklyn Investment Group held 17,635 shares of Iovance Biotherapeutics worth $61.9K as of Q1 2026.
  • Iovance Biotherapeutics was a new Brooklyn Investment Group position in Q1 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1815 holding.
  • Brooklyn Investment Group first reported a position in Iovance Biotherapeutics in Q4 2024 and has held it in 5 quarters since.
  • Brooklyn Investment Group's Iovance Biotherapeutics position peaked at $80.1K in Q2 2025.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.